Filing Details
- Accession Number:
- 0001548538-20-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-27 20:56:45
- Reporting Period:
- 2020-05-27
- Accepted Time:
- 2020-05-27 20:56:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1531048 | Inari Medical Inc. | NARI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190636 | M Steven Krausz | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1192391 | Irwin Federman | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1370817 | A Paul Matteucci | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1440514 | Us Venture Partners X Lp | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1453359 | Usvp X Affiliates Lp | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1474322 | M Casey Tansey | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1534399 | W. Richard Lewis | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1602744 | Presidio Management Group X Llc | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-27 | 2,307,142 | $0.00 | 2,307,142 | No | 4 | C | Indirect | Directly owned by USVP X |
Common Stock | Acquisiton | 2020-05-27 | 2,899,876 | $0.00 | 5,207,018 | No | 4 | C | Indirect | Directly owned by USVP X |
Common Stock | Acquisiton | 2020-05-27 | 2,278,331 | $0.00 | 7,485,349 | No | 4 | C | Indirect | Directly owned by USVP X |
Common Stock | Acquisiton | 2020-05-27 | 73,809 | $0.00 | 73,809 | No | 4 | C | Indirect | Directly owned by AFF X |
Common Stock | Acquisiton | 2020-05-27 | 92,771 | $0.00 | 166,580 | No | 4 | C | Indirect | Directly owned by AFF X |
Common Stock | Acquisiton | 2020-05-27 | 72,887 | $0.00 | 239,467 | No | 4 | C | Indirect | Directly owned by AFF X |
Common Stock | Acquisiton | 2020-05-27 | 97,962 | $19.00 | 97,962 | No | 4 | P | Indirect | Directly owned by Casey Tansey |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | Directly owned by USVP X |
No | 4 | C | Indirect | Directly owned by USVP X |
No | 4 | C | Indirect | Directly owned by USVP X |
No | 4 | C | Indirect | Directly owned by AFF X |
No | 4 | C | Indirect | Directly owned by AFF X |
No | 4 | C | Indirect | Directly owned by AFF X |
No | 4 | P | Indirect | Directly owned by Casey Tansey |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2020-05-27 | 2,307,142 | $0.00 | 2,307,142 | $0.00 |
Common Stock | Series A Preferred Stock | Disposition | 2020-05-27 | 73,809 | $0.00 | 73,809 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2020-05-27 | 2,899,876 | $0.00 | 2,899,876 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2020-05-27 | 92,771 | $0.00 | 92,771 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2020-05-27 | 2,278,331 | $0.00 | 2,278,331 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2020-05-27 | 72,887 | $0.00 | 72,887 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of the Issuer's preferred stock is convertible on a one-to-one basis into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
- The reported securities are owned directly by each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates Fund, L.P. ("AFF X") (together, the "USVP X Funds"). Presidio Management Group X, L.L.C. ("PMG X") is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds. Jonathan D. Root, a director of the issuer, Irwin Federman, Steven Krausz, Richard Lewis, Paul Matteucci and Casey Tansey are the managing members of PMG X, who may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds. Such persons and entities disclaim beneficial ownership of the reported securities held by the USVP X Funds, except to the extent of any pecuniary interest therein